KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Times Interest Earned (2016 - 2026)

Pacira BioSciences has reported Times Interest Earned over the past 17 years, most recently at $1.87 for Q1 2026.

  • For Q1 2026, Times Interest Earned rose 329.44% year-over-year to $1.87; the TTM value through Mar 2026 reached $1.46, up 130.67%, while the annual FY2025 figure was $1.1, 124.84% up from the prior year.
  • Times Interest Earned for Q1 2026 was $1.87 at Pacira BioSciences, up from $0.6 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $10.32 in Q2 2023 and troughed at -$29.76 in Q3 2024.
  • A 5-year average of $1.43 and a median of $1.87 in 2026 define the central range for Times Interest Earned.
  • On a YoY basis, Times Interest Earned climbed as much as 1336.03% in 2024 and fell as far as 681.66% in 2024.
  • Year by year, Times Interest Earned stood at -$0.9 in 2022, then surged by 1192.59% to $9.79 in 2023, then plummeted by 46.08% to $5.28 in 2024, then tumbled by 88.61% to $0.6 in 2025, then skyrocketed by 210.35% to $1.87 in 2026.
  • Business Quant data shows Times Interest Earned for PCRX at $1.87 in Q1 2026, $0.6 in Q4 2025, and $1.49 in Q3 2025.